Search Results 121-130 of 16885 for Humira

1. Ofatumumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Ofatumumab injection is also used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and ...

2. I have Medicaid or a managed Medicaid product — Cancer Patients Only - Mayo Clinic

   Because Medicaid requires little to no insurance premium or out of pocket, traditional copay and grant assistance programs are limited. However, it is important ...

3. Paromomycin (oral route) - Side effects & dosage - Mayo Clinic

   Paromomycin is used to treat acute and chronic intestinal amebiasis (bowel infection caused by a parasite in your stomach or bowels). It is also used with other ...

4. A Study Of Ritlecitinib In Adults With Hidradenitis Suppurativa, Or HS - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Pharmacogenomics: Your Own Prescription - Mayo Clinic

   Each person's genetic code is unique. Researchers focused on pharmacogenomics at Mayo Clinic are working to understand how these tiny DNA variations cause ...

6. Nipocalimab-aahu (intravenous route) - Mayo Clinic

   Nipocalimab-aahu injection is used to treat a nerve and muscle disease called generalized myasthenia gravis (gMG) in patients who are anti-acetylcholine ...

7. Drugs and Supplements that Start with S - Mayo Clinic

   Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “S” to learn about drug side effects, proper use and ...

8. Hemin (intravenous route) - Mayo Clinic

   Hemin injection is used to reduce the repeated attacks of porphyria (blood disorder) in some women during their menstrual periods after other treatments (eg, ...

9. A Study to Evaluate the Safety and Tolerability of HMPL-306 to Treat Advanced or Metastatic Solid Tumors with IDH Mutations - Mayo Clinic

   The purpose of this study is to evaluate the safety, tolerability, and preliminary effectiveness of HMPL-306 in advanced or metastatic solid tumors with IDH ...

10. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

    A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With ...